Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial) (2023) Kähler KC, Hüning S, Nashan D, Meiss F, Rafei-Shamsabadi DA, Rissmann H, Colapietro C, et al. Journal article Implementation and update of guideline-derived quality indicators for cervical cancer in gynecological cancer centers certified by the German Cancer Society (DKG) (2023) Stübs F, Beckmann M, Fehm T, Dannecker C, Follmann M, Langer T, Wesselmann S Journal article Early clinical trial unit tumor board: a real-world experience in a national cancer network (2023) Weiss L, Dorman K, Boukovala M, Schwinghammer F, Jordan P, Fey T, Hasselmann K, et al. Journal article A contemporary assessment of total neoadjuvant therapy (TNT) protocols for locally advanced rectal cancer: adoption and expert perspectives at German Cancer Society (DKG)-certified colorectal cancer centers (2023) Langheinrich M, Paasch C, Mantke R, Weber K, Benz S, Kersting S Journal article Gender-specific outcomes in immune checkpoint inhibitor therapy for advanced or metastatic urothelial cancer: a systematic review and meta-analysis (2023) Schneidewind L, Kiss B, Zengerling F, Borkowetz A, Graf S, Kranz J, Dräger DL, et al. Journal article, Review article Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa project (2023) Braulke F, Para S, Alt-Epping B, Tewes M, Bäumer M, Haberland B, Mayer-Steinacker R, et al. Journal article Cancer of unknown primary (CUP) through the lens of precision oncology: a single institution perspective (2023) Weiss L, Heinrich K, Zhang D, Dorman K, Rühlmann K, Hasselmann K, Klauschen F, et al. Journal article Diagnostic accuracy of contrast-enhanced computed tomography in assessing cervical lymph node status in patients with oral squamous cell carcinoma (2023) Struckmeier AK, Yekta E, Agaimy A, Kopp M, Buchbender M, Möst T, Lutz R, Kesting MR Journal article Predictors of cancer patients' utilization of psychooncological support: Examining patient´s attitude and physician´s recommendation (2023) Goerling U, Albus C, Bergelt C, Erim Y, Faller H, Geiser F, Hönig K, et al. Journal article Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcoma (2022) Schrenk KG, Weschenfelder W, Spiegel C, Agaimy A, Stöhr R, Hartmann A, Gassler N, et al. Journal article